AR and neoplasm: Approximately 2-fold increase in the levels of troponin-I was observed in serum of tumor-bearing nude mice treated with DOX (4 mg kg−1), whereas in tumor-bearing nude mice treated with DOX in combination with fidarestat, the levels of troponin- I were similar to untreated mice, indicating cardio-protective functions of AR inhibitor (Fig. 6A).